Janney Montgomery Scott LLC Tff Pharmaceuticals, Inc. Transaction History

Janney Montgomery Scott LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$0.31 - $0.48 $4,448 - $6,888	14,350 New	14,350 $5,000
Q2 2022 Aug 03, 2022	SELL	$3.99 - $7.22 $632,243 - $1.14 Million	-158,457 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$5.28 - $9.17 $530,914 - $922,061	-100,552 Reduced 38.82%	158,457 $1 Million
Q4 2021 Jan 27, 2022	BUY	$6.86 - $9.65 $434,601 - $611,356	63,353 Added 32.38%	259,009 $2.3 Million
Q3 2021 Oct 29, 2021	BUY	$7.21 - $10.49 $261,023 - $379,769	36,203 Added 22.7%	195,656 $1.51 Million
Q2 2021 Jul 26, 2021	BUY	$8.48 - $13.61 $297,181 - $476,962	35,045 Added 28.17%	159,453 $1.53 Million
Q1 2021 Apr 27, 2021	BUY	$12.96 - $19.75 $921,339 - $1.4 Million	71,091 Added 133.34%	124,408 $1.69 Million
Q4 2020 Jan 25, 2021	BUY	$12.74 - $18.49 $679,258 - $985,831	53,317 New	53,317 $763,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.92M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.